Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ana F. Almeida"'
Autor:
Franciele F. Scarante, Melissa A. Ribeiro, Ana F. Almeida-Santos, Francisco S. Guimarães, Alline C. Campos
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Cannabidiol (CBD) is a phytocannabinoid with a broad-range of therapeutic potential in several conditions, including neurological (epilepsy, neurodegenerative diseases, traumatic and ischemic brain injuries) and psychiatric disorders (schizophrenia,
Externí odkaz:
https://doaj.org/article/3a28f32e5b0b4d0bbe8bc75b1e7531fb
Publikováno v:
Journal of Infection and Public Health, Vol 10, Iss 3, Pp 339-342 (2017)
Invasive Haemophilus influenzae type b (Hib) disease decreased dramatically after the introduction of conjugate vaccine in routine immunization schedules.We report a case of a fifteen-months-old girl, previously healthy and vaccinated, admitted in th
Externí odkaz:
https://doaj.org/article/679907b7e78a4d9e8b86bc1eeb5e0128
Autor:
Ana F. Almeida, Margarida S. Miranda, Adriana Vinhas, Ana I. Gonçalves, Manuela E. Gomes, Márcia T. Rodrigues
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 23; Pages: 15125
The persistence of inflammatory mediators in tissue niches significantly impacts regenerative outcomes and contributes to chronic diseases. Interleukin-4 (IL4) boosts pro-healing phenotypes in macrophages (Mφ) and triggers the activation of signal t
Autor:
João C C, Ferreira, Sara, Granja, Ana F, Almeida, Fátima, Baltazar, M Sameiro T, Gonçalves, Ana, Preto, Maria João, Sousa
Publikováno v:
International journal of molecular sciences. 24(1)
Colorectal cancer (CRC) has been ranked as one of the cancer types with a higher incidence and one of the most mortal. There are limited therapies available for CRC, which urges the finding of intracellular targets and the discovery of new drugs for
Publikováno v:
Advanced Drug Delivery Reviews. 196:114815
Publikováno v:
Protein & Peptide Letters. 27:476-483
The current pharmacological strategies for the management of anxiety disorders and depression, serious conditions which are gaining greater prevalence worldwide, depend on only two therapeutic classes of mood-stabilizing drugs: Serotonin Reuptake Inh
Autor:
Fabrício A. Moreira, Thiago Roberto Lima Romero, Renata Cristina Mendes Ferreira, Igor D.G. Duarte, Daniele C. Aguiar, Ana F. Almeida-Santos
Publikováno v:
Anesthesia & Analgesia. 129:263-268
Recently, we demonstrated that the antipsychotic dopaminergic and serotoninergic agonist aripiprazole induced peripheral antinociception. However, the mechanism underlying this effect has not been fully established. Here, our aim was to identify poss
Autor:
Alline C. Campos, Melissa A Ribeiro, Francisco Silveira Guimarães, Ana F. Almeida-Santos, Franciele F. Scarante
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Frontiers in Pharmacology
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Cannabidiol (CBD) is a phytocannabinoid with a broad-range of therapeutic potential in several conditions, including neurological (epilepsy, neurodegenerative diseases, traumatic and ischemic brain injuries) and psychiatric disorders (schizophrenia,
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
2-Arachidonoylglycerol and anandamide are the main endocannabinoids, which act through cannabinoid type-1 and type-2 receptors. Among its many functions, anandamide modulates anxiety-like behaviors in the ventromedial prefrontal cortex. The role of 2
Autor:
Ana F. Almeida-Santos, Sthéfanie C.A. Gonçalves, Maria José Campagnole-Santos, Robson A.S. Santos, Laura B. Oliveira Amaral, Lucas M. Kangussu, Leonardo Augusto de Melo
Publikováno v:
Hormones and Behavior. 127:104880
Alamandine (Ala1-Arg2-Val3-Tyr4-Ile5-His6-Pro7), a heptapeptide hormone of the renin-angiotensin system (RAS), exerts its effects through the Mas-related G-protein coupled receptor of the type D, MrgD, which is expressed in different tissues, includi